Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as an adjuvant therapy in pemphigus vulgaris
IRCT20170822035834N2Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, triple-blind trial of metformin in pemphigus vulgaris (PV) and pemphigus foliaceus (PF) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: IgG1 level, IgG3 level and 2 more. Started Apr 2018; status: completed.
02
Drugs
metformin
03
Conditions
pemphigus vulgaris (PV)pemphigus foliaceus (PF)
Beyond the preview
Go deeper on IRCT20170822035834N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170822035834N2.